ProfileGDS4459 / ENSG00000182492
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 76% 80% 90% 89% 86% 83% 91% 89% 89% 93% 76% 88% 87% 51% 89% 65% 81% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 15.6276
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 25.9380
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 37.4290
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 46.8689
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 56.8186
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 66.3683
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 77.3891
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 87.2589
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 97.2789
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 107.6693
GSM623474group B, liver allograft wedge biopsie placebo treatment 15.7476
GSM623475group B, liver allograft wedge biopsie placebo treatment 27.1588
GSM623476group B, liver allograft wedge biopsie placebo treatment 36.8387
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.4651
GSM623478group B, liver allograft wedge biopsie placebo treatment 57.2789
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.9465
GSM623480group B, liver allograft wedge biopsie placebo treatment 76.0381